Pharmaceutical-lipid aspirin (PL-ASA)
PL-ASA-009
Phase 1 small_molecule completed
Quick answer
Pharmaceutical-lipid aspirin (PL-ASA) for Bioequivalence is a Phase 1 program (small_molecule) at Protalix BioTherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Protalix BioTherapeutics
- Indication
- Bioequivalence
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed